Original post on ABC7 News ROCKVILLE, Md. (7News) — There’s more good news in the fight to cure HIV. American Gene Technologies says its clinical trial has resulted in… [Read More]
American Gene Technologies® Applauds the State of Maryland for Supporting Biotech Investment
Maryland’s Biotechnology Investment Incentive Tax Credit (BIITC) program generates multiple benefits for the state American Gene Technologies, a clinical-stage biotechnology company working to cure HIV, thanks the State of Maryland… [Read More]
American Gene Technologies® Advances Closer to Demonstrating a Potential Cure for HIV
HIV cure clinical trial data shows safety and efficacy of AGT™ gene therapy treatment, the company will begin withdrawing participants from antiretrovirals in Q2 to test potential functional cure American… [Read More]
American Gene Technologies® HIV Clinical Trial Demonstrates Blood Markers of Efficacy
Data from the First Three Patients Shows Critical Markers of the HIV Cure Cell Therapy: Engraftment, Persistence, and Function of Infused Cells American Gene Technologies (AGT™), a clinical-stage biotechnology company… [Read More]
American Gene Technologies Passes Major Milestone in Potential HIV Cure Clinical Trial with Third Patient Showing No Serious Adverse Effects (SAEs)
American Gene Technologies (AGT), a clinical-stage biotechnology company, announced that the independent Data Safety and Monitoring Board (DSMB) overseeing the trial of AGT’s HIV gene therapy found no serious adverse… [Read More]
One Zero: “The Gene Fix That Could Cure HIV”
Published by: One Zero Written by: Emily Mullin Antiretroviral drugs make HIV manageable, but gene therapies could eliminate the virus altogether — provided the treatments can be made safe and economical… [Read More]
Montgomery Magazine: “Jeffrey Galvin’s BioTech Firm May Be on The Verge of Curing HIV/AIDS”
Published by: Montgomery Magazine | Issue: August – September 2019, Page 42 Written by: Jeff Thoreson | Photograph by: Kevin Allen A 3D RENDERING OF HIV VIRUS IN BLOOD STREAM… [Read More]
HIV Cure Program of American Gene Technologies Adds University of Maryland School of Medicine’s Institute of Human Virology as New Study Site to Support the Development of a Cell and Gene Therapy for HIV
ROCKVILLE, Md. — American Gene Technologies (AGT), a leading gene and cell therapy company based in Rockville, MD, selected the Institute of Human Virology (IHV) at the University of Maryland… [Read More]
C&EN: “With Several Long-acting HIV Treatments In The Works, The Newest Drugs Emphasize Convenience”
Published by: C&EN on May 12, 2019, In Volume 97, Issue 19. Written by: Megha Satyanarayana Lionel Hillard’s boss asked him to come into his office. It was the late… [Read More]
HIV Cure Program Patent Granted To American Gene Technologies
ROCKVILLE, Md., May 21, 2019 (GLOBE NEWSWIRE) — American Gene Technologies, a leading gene and cell therapy company based in Rockville, Md., was granted a second patent for its unique molecule,… [Read More]
Second Patient Cured of HIV and The Implications for American Gene Technologies’s AGT103-T
ROCKVILLE, MD, UNITED STATES, March 8, 2019 / American Gene Technologies (AGT) is pleased to see the release of information about a second individual cured of HIV in London–recently reported… [Read More]
American Gene Technologies Signs Research Agreement with NIAID for Experimental HIV/AIDS Cure Strategy
AGT signed Research Collaboration Agreement with National Institute of Allergy and Infectious Diseases for studies on AGT’s cell and gene therapy for HIV/AIDS. ROCKVILLE, MD, UNITED STATES, February 14, 2019… [Read More]
